Equities

Aarti Pharmalabs Ltd

AARTIPHARM:NSI

Aarti Pharmalabs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)658.75
  • Today's Change-28.25 / -4.11%
  • Shares traded133.92k
  • 1 Year change+68.05%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 10:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in INRView more

In 2024, Aarti Pharmalabs Ltd increased its cash reserves by 94.99%, or 115.14m. The company earned 2.16bn from its operations for a Cash Flow Margin of 11.68%. In addition the company generated 97.24m cash from financing while 2.15bn was spent on investing.
Cash flow per share33.87
Price/Cash flow per share19.44
Book value per share204.88
Tangible book value per share194.75
More ▼

Balance sheet in INRView more

Aarti Pharmalabs Ltd has a Debt to Total Capital ratio of 17.23%, a higher figure than the previous year's 0.62%.
Current ratio2.01
Quick ratio0.9611
Total debt/total equity0.2082
Total debt/total capital0.1723
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.